(Q46925682)

26 December 2017

title

Evaluation of adjuvants for protein vaccines against tuberculosis in guinea pigs (English)

1 reference

26 December 2017

1 reference

Philip J Hogarth

1

1 reference

26 December 2017

Keith J Jahans

2

1 reference

26 December 2017

Rolf Hecker

3

1 reference

26 December 2017

R Glyn Hewinson

4

1 reference

26 December 2017

Mark A Chambers

5

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

26 December 2017

published in

Vaccine

1 reference

26 December 2017

volume

21

1 reference

26 December 2017

issue

9-10

1 reference

26 December 2017

page(s)

977-982

1 reference

26 December 2017

The global tuberculosis situation and the new control strategy of the World Health Organization

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

Tuberculosis vaccine development: recent progress

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

Boosting vaccine for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

Adjuvants: current status, clinical perspectives and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

Immunity to mycobacteria with emphasis on tuberculosis: implications for rational design of an effective tuberculosis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

ESAT-6 subunit vaccination against Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

A guinea pig model of low-dose Mycobacterium bovis aerogenic infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

Immunization of mice with mycobacterial culture filtrate proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

Effective, nonsensitizing vaccination with culture filtrate proteins against virulent Mycobacterium bovis infections in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and interleukin-2 for protection against bovine tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

Evaluation of novel aggregate structures as adjuvants: composition, toxicity studies and humoral responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

Adjuvants--a balance between toxicity and adjuvanticity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

Differentiation of B cells in the bovine. Role of cytokines in immunoglobulin isotype expression

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

Generation of antigen specific CD8+ cytotoxic T cells following immunization with soluble protein formulated with novel glycoside adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

Potentiation by a novel alkaloid glycoside adjuvant of a protective cytotoxic T cell immune response specific for a preerythrocytic malaria vaccine candidate antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

Mechanism and function of a newly identified CpG DNA motif in human primary B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900548-0

7 January 2021

10.1016/S0264-410X(02)00548-0

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017